The impact of depression on adherence to organized and opportunistic breast cancer screening.
Aged
Breast Neoplasms
/ diagnosis
Cross-Sectional Studies
Depressive Disorder, Major
/ diagnosis
Early Detection of Cancer
/ psychology
Female
Health Surveys
/ statistics & numerical data
Humans
Mammography
/ psychology
Mass Screening
/ organization & administration
Middle Aged
Patient Compliance
/ psychology
Patient Health Questionnaire
/ statistics & numerical data
Practice Guidelines as Topic
Severity of Illness Index
Switzerland
/ epidemiology
Journal
European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation (ECP)
ISSN: 1473-5709
Titre abrégé: Eur J Cancer Prev
Pays: England
ID NLM: 9300837
Informations de publication
Date de publication:
01 2020
01 2020
Historique:
pubmed:
19
4
2019
medline:
16
6
2021
entrez:
19
4
2019
Statut:
ppublish
Résumé
One in five women will experience depression over her lifetime, and one out of eight will develop breast cancer. We evaluated the effect of depression on adherence to mammography in Switzerland, where opportunistic and organized screening programs coexist. We analyzed data from 3206 women aged 50-69 who participated in the Swiss Health Survey 2012. We compared mammographic rates among women with no to mild versus moderate to severe depressive symptoms. The effect of the type of screening on the odds of undertaking a mammography was calculated using multivariable logistic regression analysis. Women with moderate to severe major depressive symptoms were more likely to have had a mammography in the previous 2 years than their nondepressed or less-depressed counterparts (51 vs. 39.2%, respectively, P = 0.005). In the multivariable analysis, women with no to mild major depression living in cantons with an organized screening program had an adjusted odds ratio of 2.7 (95% confidence interval: 2.30-3.17, P < 0.001) of having had a mammography within the past 24 months compared with those living in the regions with an opportunistic screening. The adjusted odds ratio for women with moderate to severe major depression was 4.21 (95% confidence interval: 2.13-8.33, P < 0.001). In Switzerland. adherence to mammographic screening among women with moderate to severe major depression is higher than among women with no or minimal major depressive symptoms. This increased adherence is even more pronounced in regions with organized screening.
Identifiants
pubmed: 30998527
doi: 10.1097/CEJ.0000000000000520
pii: 00008469-202001000-00007
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
53-59Références
Abrams RC, Lachs M, McAvay G, Keohane DJ, Bruce ML. Predictors of self-neglect in community-dwelling elders. Am J Psychiatry. 2002); 159:1724–1730
Aggarwal A, Freund K, Sato A, Adams-Campbell LL, Lopez AM, Lessin LS, et al. Are depressive symptoms associated with cancer screening and cancer stage at diagnosis among postmenopausal women? The Women’s Health Initiative observational cohort. J Womens Health (Larchmt). 2008); 17:1353–1361
Aggarwal A, Pandurangi A, Smith W. Disparities in breast and cervical cancer screening in women with mental illness: a systematic literature review. Am J Prev Med. 2013); 44:392–398
Baer N, Schuler D, Füglister-Dousse S, Moreau-Gruet F. Depressionen in der Schweizer Bevölkerung: Daten zur Epidemiologie, Behandlung und sozial-beruflichen Integration. (2013).. Available at: https://www.obsan.admin.ch/sites/default/files/publications/2015/obsan_56_bericht.pdf. [Accessed 4 October 2018]
Berry DA, Cronin KA, Plevritis SK, Fryback DG, Clarke L, Zelen M, et al. Effect of screening and adjuvant therapy on mortality from breast cancer. N Engl J Med. 2005); 353:1784–1792
Blackwell DL, Martinez ME, Gentleman JF. Women’s compliance with public health guidelines for mammograms and pap tests in Canada and the United States: an analysis of data from the Joint Canada/United States Survey Of Health. Womens Health Issues. 2008); 18:85–99
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2018); 68:394–424
Bulliard JL, Ducros C, Dayer E, Arzel B, Levi F. Variation in performance in low-volume mammography screening programmes: experience from Switzerland. Cancer Epidemiol. 2011); 35:293–297
Carney CP, Jones LE. The influence of type and severity of mental illness on receipt of screening mammography. J Gen Intern Med. 2006); 21:1097–1104
Carney CP, Allen J, Doebbeling BN. Receipt of clinical preventive medical services among psychiatric patients. Psychiatr Serv. 2002); 53:1028–1030
De Hert M, Cohen D, Bobes J, Cetkovich-Bakmas M, Leucht S, Ndetei DM, et al. Physical illness in patients with severe mental disorders. II. Barriers to care, monitoring and treatment guidelines, plus recommendations at the system and individual level. World Psychiatry. 2011); 10:138–151
DE Hert M, Correll CU, Bobes J, Cetkovich-Bakmas M, Cohen D, Asai I, et al. Physical illness in patients with severe mental disorders. I. Prevalence, impact of medications and disparities in health care. World Psychiatry. 2011); 10:52–77
Druss BG. Improving medical care for persons with serious mental illness: challenges and solutions. J Clin Psychiatry. (2007).; 68Suppl 440–44
Druss BG, Rosenheck RA, Desai MM, Perlin JB. Quality of preventive medical care for patients with mental disorders. Med Care. 2002); 40:129–136
Druss BG, Rask K, Katon WJ. Major depression, depression treatment and quality of primary medical care. Gen Hosp Psychiatry. 2008); 30:20–25
Duport N. Characteristics of women using organized or opportunistic breast cancer screening in France. Analysis of the 2006 French Health, Health Care and Insurance Survey. Rev Epidemiol Sante Publique. 2012); 60:421–430
Eichholzer M, Richard A, Rohrmann S, Schmid SM, Leo C, Huang DJ, Güth U. Breast cancer screening attendance in two Swiss regions dominated by opportunistic or organized screening. BMC Health Serv Res. 2016a); 16:519
Eichholzer M, Richard A, Rohrmann S, Schmid S, Guth U. Overweight, obesity, and breast cancer screening: results from the 2012 Swiss Health Survey. Eur J Cancer Prev. 2016b); 25:130–136
El-Charnoubi WA, Svendsen JB, Tange UB, Kroman N. Women with inoperable or locally advanced breast cancer – what characterizes them? A retrospective review of 157 cases. Acta Oncol. 2012); 51:1081–1085
Farasatpour M, Janardhan R, Williams CD, Margenthaler JA, Virgo KS, Johnson FE. Breast cancer in patients with schizophrenia. Am J Surg. 2013); 206:798–804
Gotzsche PC, Nielsen M. Screening for breast cancer with mammography. Cochrane Database Syst Rev. 2011); 2011:CD001877
Green CA, Pope CR. Depressive symptoms, health promotion, and health risk behaviors. Am J Health Promot. 2000); 15:29–34
Independent UKPoBCS; Independent UKPoBCS. The benefits and harms of breast cancer screening: an independent review. Lancet. 2012); 380:1778–1786
Kempe KL, Larson RS, Shetterley S, Wilkinson A. Breast cancer screening in an insured population: whom are we missing?. Perm J. 2013); 17:38–44
Kisely S, Sadek J, MacKenzie A, Lawrence D, Campbell LA. Excess cancer mortality in psychiatric patients. Can J Psychiatry. 2008); 53:753–761
Kisely S, Crowe E, Lawrence D. Cancer-related mortality in people with mental illness. JAMA Psychiatry. 2013); 70:209–217
Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001); 16:606–613
Kronman AC, Freund KM, Heeren T, Beaver KA, Flynn M, Battaglia TA. Depression and anxiety diagnoses are not associated with delayed resolution of abnormal mammograms and pap tests among vulnerable women. J Gen Intern Med. 2012); 27:452–457
Lawrence D, Hancock KJ, Kisely S. The gap in life expectancy from preventable physical illness in psychiatric patients in Western Australia: retrospective analysis of population based registers. BMJ. 2013); 346:f2539
Liu BY, O’Malley J, Mori M, Fagnan LJ, Lieberman D, Morris CD, et al. The association of type and number of chronic diseases with breast, cervical, and colorectal cancer screening. J Am Board Fam Med. 2014); 27:669–681
Lord O, Malone D, Mitchell AJ. Receipt of preventive medical care and medical screening for patients with mental illness: a comparative analysis. Gen Hosp Psychiatry. 2010); 32:519–543
Ludman EJ, Ichikawa LE, Simon GE, Rohde P, Arterburn D, Operskalski BH, et al. Breast and cervical cancer screening specific effects of depression and obesity. Am J Prev Med. 2010); 38:303–310
Masterson EA, Hopenhayn C, Christian WJ. Self-reported mental health status and recent mammography screening. J Womens Health (Larchmt). 2010); 19:1569–1576
Miles A, Cockburn J, Smith RA, Wardle J. A perspective from countries using organized screening programs. Cancer. 2004); 101:1201–1213
Mitchell AJ, Pereira IE, Yadegarfar M, Pepereke S, Mugadza V, Stubbs B. Breast cancer screening in women with mental illness: comparative meta-analysis of mammography uptake. Br J Psychiatry. 2014); 205:428–435
Montagna G, Schneeberger AR, Rossi L, Ichikawa LE, Operskalski BH, Arterburn D, et al. Can we make a portrait of women with inoperable locally advanced breast cancer?. Breast. 2017); 33:83–90
Musuuza JS, Sherman ME, Knudsen KJ, Sweeney HA, Tyler CV, Koroukian SM. Analyzing excess mortality from cancer among individuals with mental illness. Cancer. 2013); 119:2469–2476
Osborn DP, Levy G, Nazareth I, Petersen I, Islam A, King MB. Relative risk of cardiovascular and cancer mortality in people with severe mental illness from the United Kingdom’s General Practice Rsearch Database. Arch Gen Psychiatry. 2007); 64:242–249
Palencia L, Espelt A, Rodriguez-Sanz M, Puigpinós R, Pons-Vigués M, Pasarín MI, et al. Socio-economic inequalities in breast and cervical cancer screening practices in Europe: influence of the type of screening program. Int J Epidemiol. 2010); 39:757–765
Patten SB, Williams JV, Lavorato DH, Eliasziw M. The effect of major depression on participation in preventive health care activities. BMC Public Health. 2009); 9:87
Peto J, Gilham C, Fletcher O, Matthews FE. The cervical cancer epidemic that screening has prevented in the UK. Lancet. (2004); 364:249–256
Peytremann-Bridevaux I, Voellinger R, Santos-Eggimann B. Healthcare and preventive services utilization of elderly Europeans with depressive symptoms. J Affect Disord. 2008); 105:247–252
Pirraglia PA, Sanyal P, Singer DE, Ferris TG. Depressive symptom burden as a barrier to screening for breast and cervical cancers. J Womens Health (Larchmt). 2004); 13:731–738
Quinn M, Babb P, Jones J, Allen E. Effect of screening on incidence of and mortality from cancer of cervix in England: evaluation based on routinely collected statistics. BMJ. 1999); 318:904–908
Quintero E, Castells A, Bujanda L, Cubiella J, Salas D, Lanas Á, et al. Colonoscopy versus fecal immunochemical testing in colorectal-cancer screening. N Engl J Med. 2012); 366:697–706
Ronco G, Segnan N, Giordano L, Pilutti S, Senore C, Ponti A, Volante R. Interaction of spontaneous and organised screening for cervical cancer in Turin, Italy. Eur J Cancer. 1997); 33:1262–1267
Schneeberger AR, Schwartz BJ. The Swiss Mental Health Care System. Psychiatr Serv. 2018); 69:126–128
Schweizerische Gesundheitsbefragung; Schweizerische Gesundheitsbefragung. 2012. Available at: http://www.sgb12.bfs.admin.ch. [Accessed 4 October 2018]
Stecker T, Fortney JC, Prajapati S. How depression influences the receipt of primary care services among women: a propensity score analysis. J Womens Health (Larchmt). 2007); 16:198–205
Thornicroft G. Physical health disparities and mental illness: the scandal of premature mortality. Br J Psychiatry. 2011); 199:441–442
Vigod SN, Kurdyak PA, Stewart DE, Gnam WH, Goering PN. Depressive symptoms as a determinant of breast and cervical cancer screening in women: a population-based study in Ontario, Canada. Arch Womens Ment Health. 2011); 14:159–168
Walsh B, Silles M, O’Neill C. The importance of socio-economic variables in cancer screening participation: a comparison between population-based and opportunistic screening in the EU-15. Health Policy. 2011); 101:269–276
Wittchen HU, Jacobi F. Size and burden of mental disorders in Europe--a critical review and appraisal of 27 studies. Eur Neuropsychopharmacol. 2005); 15:357–376
Xiang X. Serious psychological distress as a barrier to cancer screening among women. Womens Health Issues. 2015); 25:49–55